For instance, previous studies have demonstrated that elevated levels of ACTR3 correlate with poor survival outcomes in multiple cancer types, including head and neck squamous cell carcinoma and liver hepatocellular carcinoma.[38,44] The ability to stratify patients based on gene expression not only enhances prognostic accuracy but also facilitates the development of personalized treatment strategies. This evidence concerns the gene ACTR3 and cancer.